Skip to main content
UTHR logo
UTHR
(NASDAQ)
United Therapeutics Corporation
$529.53-- (--)
Loading... - Market loading

United Therapeutics (UTHR) Stock Price & Financial Analysis

United Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$519.01 - $532.12
52-Week High$609.35
52-Week Low$272.12
Open$523.23
Volume232.53K
Average Volume (3M)504.01K
Market Cap24.99B
Shares Outstanding47.20M
P/E Ratio (TTM)19.41
Forward P/E18.44
Price to Sales (P/S)7.88
Price to Book (P/B)4.24
EV/EBITDA14.39
Revenue (TTM)3.17B
Net Income (TTM)1.29B
Free Cash Flow (TTM)1.01B
EPS (TTM)$27.00
Profit Margin40.61%
Operating Margin45.34%
Return on Equity (ROE)21.82%
Debt to Equity0.00
50-Day MA$550.21
200-Day MA$512.07
52-Week Change73.27%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About United Therapeutics

What is the current stock price for UTHR?

As of the latest trading session, UTHR stock trades at $529.53. The 52-week range is $272.12–$609.35, with a day range of $519.01–$532.12.

What is the P/E ratio for UTHR?

United Therapeutics's trailing P/E ratio is 19.4, meaning investors pay $19.4 for every $1 of annual earnings. The forward P/E is 18.4, reflecting analyst expectations for future earnings. United Therapeutics operates in the Healthcare sector.

Does UTHR pay dividends?

United Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for UTHR?

Based on 9 analysts, the consensus for UTHR is Buy.

What is the market cap of UTHR?

United Therapeutics's market capitalization is $24.99B, classifying it as a large-cap company. United Therapeutics operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.